Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROactive: Pioglitazone in Type 2 Diabetes with Macrovascular Disease
NCT00174993Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2001
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started May 2001; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00174993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174993.